我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
OG-L002 is a potent and specific LSD1 inhibitor with IC50 of 20 nM, exhibiting 36- and 69-fold selectivity over MAO-B and MAO-A, respectively.
| Cas No.: |
1357302-64-7 |
| 名称: |
[1,1'-Biphenyl]-3-ol, 4'-[(1R,2S)-2-aminocyclopropyl]-4'-((1R,2S)-2-Aminocyclopropyl)biphenyl-3-o |
| 别名: |
OGL002,OG L002,OGL-002 |
| SMILES: |
C1[C@@H]([C@H]1N)C2=CC=C(C=C2)C3=CC(=CC=C3)O |
| 分子式: |
C15H15NO |
| 分子量: |
225.29 |
| 纯度: |
|
| 保存条件: |
2 years -20°C powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
OG-L002 potently inhibits HSV IE gene expression in both HeLa and HFF cells with IC50 of ~10 μM and ~3 μM, respectively. OG-L002 treatment (50 μM ) results in the reduced production of progeny virus with no significant toxicity in HeLa or HFF cells. OG-L |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
| TITLE |
DOWNLOAD |
| MSDS_3392_DC5204_1357302-64-7 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
询盘
